Latest news
RMD Maintained by RBC Capital -- Price Target Raised to $244 - GuruFocusGuruFocus · Fri, 07 Aug 2026 21:14:24 GMTRMD Maintained by Keybanc -- Price Target Lowered to $255 - GuruFocusGuruFocus · Fri, 07 Aug 2026 20:31:49 GMTRMD Maintained by Wells Fargo -- Price Target Lowered to $215 - GuruFocusGuruFocus · Fri, 07 Aug 2026 20:23:40 GMTRMD Maintained by Piper Sandler -- Price Target Lowered to $225 - GuruFocusGuruFocus · Fri, 07 Aug 2026 19:09:29 GMTResMed Inc (RMD) (Q4 2026) Earnings Call Highlights: Strong Reve - GuruFocusGuruFocus · Fri, 07 Aug 2026 04:34:49 GMTRMD Looks 18.7% Undervalued on GF Value™ - GuruFocusGuruFocus · Fri, 07 Aug 2026 03:21:55 GMTIs ResMed Inc (RMD) Undervalued After Q4 Earnings Miss? EPS at $ - GuruFocusGuruFocus · Thu, 06 Aug 2026 21:01:53 GMTResMed Inc (RMD) Stock Up 3.7% and Still Undervalued -- GF Score: 90/100 - GuruFocusGuruFocus · Wed, 05 Aug 2026 00:39:40 GMT